SCHEMBL10025142

SCHEMBL10025142

Cc1cc2c(cc1-c1ccc3ccccc3n1)-c1cc(N(c3ccccc3)c3ccccc3)c(C)cc1C2(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 6/20 0.38
CYP1A2 P05177 1/20 0.38
NPC1 O15118 5/20 0.34
RAB9A P51151 5/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
TERT O14746 2/20 0.33
PDE10A Q9Y233 1/20 0.33
PTGS2 P35354 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GMNN O75496 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10025144 0.99 AR (0.37) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025134 0.93 CYP1A2 (0.40) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025137 0.92 CYP1A2 (0.39) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025143 0.92 CYP1A2 (0.35) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025115 0.88 AR (0.46) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025116 0.84 CYP1A2 (0.45) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025102 0.82 CYP1A2 (0.48) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025138 0.82 RXRA (0.34) CYP1A2MAPTKDM4EALDH1A1CYP3A4
SCHEMBL10025112 0.81 CYP1A2 (0.47) ARCYP1A2NPC1RAB9AMEN1
SCHEMBL10025129 0.78 RXRA (0.33) CYP1A2MAPTKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110294-B2 Fluorene compound; steric hindrance CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-8110294-B2 Fluorene compound; steric hindrance CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20080200736-A1 MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2008-08-21 US disclosed
US-20080200736-A1 MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2008-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200736-A1 MATERIAL FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING THE SAME LEF1, FMNL1, AFF1 AR 2534/4885CYP1A2 600/4885NPC1 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.